Interleukin 10 rs1800872 T>G polymorphism was associated with an increased risk of esophageal cancer in a chinese population

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3443-3447

  Sun, Jia Ming ^a   Li, Qiong ^a   Gu, Hai Yong ^b   Chen, Yi Jang ^c   Wei, Ji Shu ^c   Zhu, Quan ^c   Chen, Liang ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; Esophageal cancer; IL10; Molecular epidemiology; Polymorphisms

Indexed keywords

EID: 84882574094     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3443     Document Type: Article

References (20)

1. Akdis M (2006). Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol, 18, 738-44.
2. Berrino F, De Angelis R, Sant M, et al (2007). Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol, 8, 773-83.
3. Chen X, Li S, Yang Y, et al (2012). Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. J Thromb Haemost, 10, 1508-14.
4. Couper KN, Blount DG, Riley EM (2008). IL-10: the master regulator of immunity to infection. J Immunol, 180, 5771-7.
5. Eskdale J, Kube D, Tesch H, Gallagher G (1997). Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics, 46, 120-8.
6. Goswami R, Kaplan MH (2011). A brief history of IL-9. J Immunol, 186, 3283-8.
7. Gu H, Ding G, Zhang W, et al (2012). Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep, 39, 9105-11.
8. Howell WM, Rose-Zerilli MJ (2007). Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr, 137, S194-9.
9. Imagawa Y, Satake K, Kato Y, Tahara H, Tsukuda M (2004). Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model. Auris Nasus Larynx, 31, 239-45.
10. Jebreel A, Mistry D, Loke D, et al (2007). Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol, 121, 246-52.
11. Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96.
12. Liu H, Jacobs BS, Liu J, et al (2000). Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: nonneoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother, 49, 319-24.
13. Macfarlane GJ, Boyle P (1994). The epidemiology of oesophageal cancer in the UK and other European countries. J R Soc Med, 87, 334-7.
14. Oh SS, Chang SC, Cai L, et al (2010). Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Int J Cancer, 127, 2169-82.
15. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
16. Shinomiya T, Mori T, Ariyama Y, et al (1999). Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer, 24, 337-44.
17. Trinchieri G (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 3, 133-46.
18. Uyttenhove C, Simpson RJ, Van Snick J (1988). Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A, 85, 6934-8.
19. Wu C, Hu Z, He Z, Jia W, et al (2011). Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet, 43, 679-84.
20. Yang XR, Pfeiffer RM, Wheeler W, et al (2009). Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. Int J Cancer, 125, 2912-7.